According to Ampio Pharmaceuticals's latest financial reports the company's total debt is $0.27 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | $0.61 M | -33.62% |
2021-12-31 | $0.92 M | -23.49% |
2020-12-31 | $1.2 M | -17.7% |
2019-12-31 | $1.46 M | 173.56% |
2018-12-31 | $0.53 M | |
2015-12-31 | $4.92 M | |
2010-12-31 | $2.13 M | |
2007-12-31 | $0.02 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $29.33 B | 10,705,009.49% | ๐บ๐ธ USA |
Pfizer PFE | $70.84 B | 25,855,739.42% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $15.62 B | 5,703,549.64% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $2.70 B | 986,359.85% | ๐บ๐ธ USA |
Rigel Pharmaceuticals RIGL | $60.57 M | 22,009.12% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | N/A | N/A | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | $0.33 B | 122,887.59% | ๐บ๐ธ USA |